Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|1|1|31-49

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.1, 2002-02, pp. : 31-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The JNK pathway as a therapeutic target for diabetes

By Kaneto Hideaki  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 581-592

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Cannabinoids in CNS Disease

By Croxford J.L.  

CNS Drugs, Vol. 17, Iss. 3, 2003-01 ,pp. : 179-202

Adis International

Access to resources Recommend Favorite

Targeting the Nogo-A Signalling Pathway to Promote Recovery Following Acute CNS Injury

By  

Current Pharmaceutical Design, Vol. 13, Iss. 24, 2007-08 ,pp. : 2470-2484

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of drugs targeting the arginase pathway in asthma

By Ricciardolo Fabio LM   Zaagsma Johan   Meurs Herman  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1221-1231

Informa Healthcare

Access to resources Recommend Favorite

Ubiquitin-Proteasome Pathway Components as Therapeutic Targets for CNS Maladies

By  

Current Pharmaceutical Design, Vol. 11, Iss. 29, 2005-11 ,pp. : 3807-3828

Bentham Science Publishers

Access to resources Recommend Favorite